share_log

Reported Earlier, Intra-Cellular Therapies Prices Public Offering Of 6,849,316 Common Shares At $73/Share

Reported Earlier, Intra-Cellular Therapies Prices Public Offering Of 6,849,316 Common Shares At $73/Share

此前報道，細胞內療法將6,849,316股普通股的公開發行定價爲每股73美元
Moomoo 24/7 ·  04/18 03:42

All of the shares in the offering will be sold by Intra-Cellular Therapies, with gross proceeds to Intra-Cellular Therapies expected to be $500.0 million before deducting underwriting discounts and commissions and offering expenses.

此次發行的所有股份將由細胞內療法出售，在扣除承保折扣和佣金以及發行費用之前，細胞內療法的總收益預計爲5億美元。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論